K-pop

Seongri Releases "Sad Rain," the Bonus Track from the "Legend of the Unknown" Victory

Collaboration with Kim Jin-ryong, Composer of “Southbound Train”

KIM HYUNSIK
2026-08-20 16:06:43
[Edaily Starin Reporter KIM HYUNSIK ] Singer Seong-ri is set to release a special track as the grand prize for winning MBN’s trot survival program “Legend of the Unknown.”
(Photo courtesy of C2K Entertainment)
According to her agency, C2K Entertainment, on the 20th, Seong-ri will release her new song “Sad Rain” at 6:00 p.m. via various online music platforms.
“Sad Rain” is an alternative rock track centered on the theme of heartfelt longing for a loved one. Composer Kim Jin-ryong, who wrote the hit song “Southbound Train,” handled the lyrics, composition, and arrangement.
The agency said, “This song was produced with a focus on maximizing Seong-ri’s unique vocal style, which is both soft and powerful,” and asked fans to look forward to it.
Seong-ri previously was a member of the idol groups K-Boys and Rainz. He gained popularity after winning the reality show “Legend of the Unknown,” which concluded last May. Seong-ri gave a sneak peek of his new song performance on the MBN variety show “Legendary Man,” which aired the day before.

Economy

Corporation

IT·Science

Economy

Targeting Physical AI Components… SamsungElectroMechanics and LG Innotek’s R&D Spending Nears 900 Billion Won

SamsungElectroMechanics and LG Innotek are expanding the technologies they have accumulated in mobile and IT components into the fields of AI servers, autonomous driving, and humanoid robots. They are…
2026-08-20 17:54:18

Corporation

SILICON 2 Co.,Ltd., a 'K-Beauty Distributor,' Sets Sights on the Wellness Market… Global Launch of 'Gamtan Bra'

SILICON 2 Co.,Ltd., a K-Beauty distribution platform company, is expanding its business into the wellness sector by introducing the innerwear brand “Gamtan Bra” to the global market. SILICON 2 Co.,Ltd…
2026-08-20 18:39:16

IT·Science

Could a Change in Indications Be a Blessing in Disguise?… What AprilBio Co.,Ltd. Needs to Do for 'APB-A1' to Make a Comeback

AprilBio Co.,Ltd.(397030)Since “APB-A1” (Lu AG22515), which was licensed to Lundbeck, failed to demonstrate the expected clinical efficacy in thyroid-associated ophthalmopathy (TED), the company is no…
2026-08-20 17:32:02